Article Text

Download PDFPDF
Concise report
Rheumatoid arthritis and polymyalgia rheumatica occurring after immune checkpoint inhibitor treatment
  1. Rakiba Belkhir1,
  2. Sébastien Le Burel2,
  3. Laetitia Dunogeant3,
  4. Aurélien Marabelle4,
  5. Antoine Hollebecque4,
  6. Benjamin Besse5,
  7. Alexandra Leary5,
  8. Anne-Laure Voisin6,
  9. Clémence Pontoizeau7,
  10. Laetitia Coutte8,
  11. Edouard Pertuiset9,
  12. Gaël Mouterde10,
  13. Olivier Fain11,
  14. Olivier Lambotte2,12,
  15. Xavier Mariette1,13
  1. 1Rheumatology, Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpitaux Universitaires Paris-Sud, Le Kremlin-Bicêtre, France
  2. 2AP-HP, Hôpital Bicêtre, Service de Médecine Interne et Immunologie clinique, Le Kremlin-Bicêtre, France
  3. 3Service de rhumatologie et médecine interne, Centre Hospitalier du Pays d’Aix, Aix-en-Provence, France
  4. 4Département d’Innovation Thérapeutique et Essais Précoces (DITEP), Gustave Roussy Cancer Campus, France
  5. 5Gustave Roussy Cancer Campus, Villejuif; Univ. Paris-Sud, Université Paris-Saclay, Villejuif, France
  6. 6Institut Gustave Roussy, Unité Fonctionnelle de Pharmacovigilance, Villejuif, France
  7. 7Service de médecine nucléaire, Centre Hospitalier de Saint Brieuc, 22000 Saint Brieuc, France
  8. 8AP-HP, université Paris-Descartes, hôpital Cochin, centre de référence maladies auto-immunes et systémiques rares, service de médecine interne, Paris, France
  9. 9Rheumatology Department, René Dubos Hospital, Pontoise, France
  10. 10Rheumatology Department, Lapeyronie Hospital and &EA 2415, Montpellier, France
  11. 11AP-HP, Service de Médecine Interne, Hôpital Saint-Antoine, Université Paris, France
  12. 12CEA, DSV/iMETI, Division d’Immunovirologie, IDMIT, Fontenay-aux-Roses, France
  13. 13Université Paris Sud, INSERM, Center for Immunology of Viral Infections and Autoimmune Diseases, Le Kremlin-Bicêtre, France
  1. Correspondence to Dr Xavier Mariette, Rheumatology, Hôpital Bicêtre, 78 rue du Général Leclerc, 94275 LeKremlin Bicêtre, France; xavier.mariette{at}bct.aphp.fr

Footnotes

  • Contributors All the authors contributed to the manuscript: conception and design (RB and XM), collection of data (all authors). All the authors read and validated the final version of the manuscript.

  • Funding The authors received no financial support for the research, authorship and/or publication of this article.

  • Competing interests AM reports being one of the principal investigator for clinical trials from Roche/Genentech, BMS, Merck (MSD), Pfizer, Lytix pharma, Eisai, Astra Zeneca/Medimmune, Bayer, Celgene. AH reports advisory boards for Amgen and Lilly. OL reports consulting for MSD, BMS and Genzyme and received travel support from LFB and CSL Behring. All the others authors declared no conflict of interest for this work.

  • Patient consent Informed consent was obtained from all subjects, and the study was approved by the local ethics committee.

  • Ethics approval local ethics committee.

  • Provenance and peer review Not commissioned; externally peer reviewed.

View Full Text

Statistics from Altmetric.com

Footnotes

  • Contributors All the authors contributed to the manuscript: conception and design (RB and XM), collection of data (all authors). All the authors read and validated the final version of the manuscript.

  • Funding The authors received no financial support for the research, authorship and/or publication of this article.

  • Competing interests AM reports being one of the principal investigator for clinical trials from Roche/Genentech, BMS, Merck (MSD), Pfizer, Lytix pharma, Eisai, Astra Zeneca/Medimmune, Bayer, Celgene. AH reports advisory boards for Amgen and Lilly. OL reports consulting for MSD, BMS and Genzyme and received travel support from LFB and CSL Behring. All the others authors declared no conflict of interest for this work.

  • Patient consent Informed consent was obtained from all subjects, and the study was approved by the local ethics committee.

  • Ethics approval local ethics committee.

  • Provenance and peer review Not commissioned; externally peer reviewed.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.